会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • LARGE-SCALE SYNTHESIS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS
    • 选择性雄激素受体调节剂的大规模合成
    • WO2004062612A3
    • 2004-11-04
    • PCT/US2004000618
    • 2004-01-12
    • GTX INCSTEINER MITCHELL SCHUNG KIWONDALTON JAMESMILLER DUANE DVEVERKA KAREN A
    • STEINER MITCHELL SCHUNG KIWONDALTON JAMESMILLER DUANE DVEVERKA KAREN A
    • C07C231/12C07C235/24C07C231/00
    • C07C231/12C07C235/24
    • The present invention relates to a synthetic process for the preparation of a novel class of androgen receptor targeting agents (ARTA) which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds which are selective androgen receptor modulators (SARM) which are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example conditions associated with Androgen Decline in Aging Male (ADAM), such as fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia, osteoporosis, and alterations in mood and cognition; c) treatment of conditions associated with Androgen Decline in Female (ADIF), such as sexual dysfunction, decreased sexual libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, alterations in cognition and mood, depression, anemia, hair loss, obesity and endometriosis, d) treatment and/or prevention of chronic muscular wasting; e) decreasing the incidence of, halting or causing a regression of prostate cancer; f) oral androgen replacement; g) preventing and/or treating dry eye conditions; h) treatment and/or prevention of begnin prostate hyperplasia (BPH); I) inducing apoptosis in a cancer cell; j) treatment and/or prevention of cancers of female sexual organs such as breast cancer, uterine cancer and ovarian cancer; and/or other clinical therapeutic and/or diagnostic areas. The process of the present invention is suitable for large-scale preparation, since all of the steps give rise to highly pure compounds, thus avoiding complicated purification procedures which ultimately lower the yield. Thus the present invention provides methods for the synthesis of non-steroidal agonist compounds, that can be used for industrial large-scale synthesis, and that provide highly pure products in high yield.
    • 本发明涉及一种制备新型雄激素受体靶向剂(ARTA)的合成方法,其显示了雄激素受体的非甾体配体的雄激素和合成代谢活性。 这些药物定义了一种新的亚类化合物,它们是选择性雄激素受体调节剂(SARM),其可用于a)男性避孕; b)治疗多种激素相关病症,例如与衰老男性(ADAM)中的雄激素降低相关的病症,例如疲劳,抑郁症,性欲减退,性功能障碍,勃起功能障碍,性腺机能减退,骨质疏松症,脱发,贫血, 肥胖症,肌肉减少症,骨质减少症,骨质疏松症以及情绪和认知改变; c)治疗与女性雄激素降低(ADIF)有关的病症,例如性功能障碍,性欲减退,性腺机能减退,肌肉减少症,骨质减少,骨质疏松症,认知和情绪改变,抑郁症,贫血,脱发,肥胖症和子宫内膜异位症,d )治疗和/或预防慢性肌肉消瘦; e)降低前列腺癌的发病率,停止或导致其消退; f)口服雄激素替代物; g)预防和/或治疗干眼症; h)治疗和/或预防begnin前列腺增生(BPH); I)诱导癌细胞凋亡; j)治疗和/或预防女性性器官的癌症,如乳腺癌,子宫癌和卵巢癌; 和/或其他临床治疗和/或诊断领域。 本发明的方法适用于大规模制备,因为所有步骤产生高纯度化合物,因此避免了复杂的纯化程序,最终降低了收率。 因此,本发明提供了用于合成非甾体激动剂化合物的方法,其可以用于工业大规模合成,并且以高收率提供高纯度产物。